RUA Life Sciences (FRA:AOHA) Additional Paid-In Capital : €27.33 Mil(As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is RUA Life Sciences Additional Paid-In Capital?

RUA Life Sciences's quarterly additional paid-in capital declined from Sep. 2022 (€26.96 Mil) to Mar. 2023 (€26.72 Mil) but then increased from Mar. 2023 (€26.72 Mil) to Sep. 2023 (€27.33 Mil).

RUA Life Sciences's annual additional paid-in capital increased from Mar. 2021 (€13.67 Mil) to Mar. 2022 (€28.20 Mil) but then declined from Mar. 2022 (€28.20 Mil) to Mar. 2023 (€26.72 Mil).

RUA Life Sciences Additional Paid-In Capital Historical Data

The historical data trend for RUA Life Sciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences Additional Paid-In Capital Chart

RUA Life Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Additional Paid-In Capital

Get a 7-Day Free Trial

5.31

5.10

13.67

28.20

26.72

RUA Life Sciences Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Additional Paid-In Capital	Get a 7-Day Free Trial															27.52	28.20	26.96	26.72	27.33

RUA Life Sciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

RUA Life Sciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of RUA Life Sciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

RUA Life Sciences (FRA:AOHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (FRA:AOHA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

RUA:UK

Address

2 Drummond Crescent, Scotland, Irvine, Ayrshire, GBR, KA11 5AN

Website

https://www.rualifesciences.com

RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives its major revenue from the USA and has a presence in Europe and the Rest of the world.

RUA Life Sciences (FRA:AOHA) Headlines

No Headlines